Article
Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with argininaemia diagnosed by newborn screening.
Journal of inherited metabolic disease - 1 Dec 2009
Edwards R L, Moseley K, Watanabe Y, Wong L J, Ottina J, Yano S
Abstract excerpt
Newborn screening makes possible the early identification and treatment of asymptomatic ARG1-deficient patients; however, it is unknown whether early intervention prevents neurological insults. We identified a full-term Hispanic male infant with argininaemia by newborn screening with a serum arginine of 327 µmol/L (reference values 0-140); ARG1 was undetectable on enzyme assay. Sequence analysis of ARG1 revealed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
